These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30225804)

  • 1. Rapid screening for cognitive deficits in attention deficit and hyperactivity disorders with the screen for cognitive impairment in psychiatry.
    Tourjman SV; Potvin S; Corbalan F; Djouini A; Purdon SE; Stip E; Juster RP; Kouassi E
    Atten Defic Hyperact Disord; 2019 Jun; 11(2):139-147. PubMed ID: 30225804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The screen for cognitive impairment in psychiatry (SCIP) is associated with disease severity and cognitive complaints in major depression.
    Tourjman SV; Juster RP; Purdon S; Stip E; Kouassi E; Potvin S
    Int J Psychiatry Clin Pract; 2019 Mar; 23(1):49-56. PubMed ID: 29553848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of adult attention deficit hyperactivity disorder with cognitive complaint: Experience of a French memory center.
    Pierre M; Cogez J; Lebain P; Loisel N; Lalevée C; Bonnet AL; De La Sayette V; Viader F
    Rev Neurol (Paris); 2019 Jun; 175(6):358-366. PubMed ID: 31056192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brief cognitive assessment instruments in schizophrenia and bipolar patients, and healthy control subjects: a comparison study between the Brief Cognitive Assessment Tool for Schizophrenia (B-CATS) and the Screen for Cognitive Impairment in Psychiatry (SCIP).
    Cuesta MJ; Pino O; Guilera G; Rojo JE; Gómez-Benito J; Purdon SE; Franco M; Martínez-Arán A; Segarra N; Tabarés-Seisdedos R; Vieta E; Bernardo M; Crespo-Facorro B; Mesa F; Rejas J
    Schizophr Res; 2011 Aug; 130(1-3):137-42. PubMed ID: 21652178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting impairment in major life activities and occupational functioning in hyperactive children as adults: self-reported executive function (EF) deficits versus EF tests.
    Barkley RA; Fischer M
    Dev Neuropsychol; 2011; 36(2):137-61. PubMed ID: 21347918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for cognitive impairment among patients with work-related stress complaints in Denmark: validation and evaluation of objective and self-report tools.
    Jensen JH; Miskowiak KW; Purdon SE; Thomsen JF; Eller NH
    Scand J Work Environ Health; 2022 Jan; 48(1):71-80. PubMed ID: 34580738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships Between Functional Outcomes and Symptomatic Improvement in Atomoxetine-Treated Adult Patients with Attention-Deficit/Hyperactivity Disorder: Post Hoc Analysis of an Integrated Database.
    De Bruyckere K; Bushe C; Bartel C; Berggren L; Kan CC; Dittmann RW
    CNS Drugs; 2016 Jun; 30(6):541-58. PubMed ID: 27224994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical correlates of working memory deficits in youth with and without ADHD: A controlled study.
    Fried R; Chan J; Feinberg L; Pope A; Woodworth KY; Faraone SV; Biederman J
    J Clin Exp Neuropsychol; 2016; 38(5):487-96. PubMed ID: 26902180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimising screening for cognitive dysfunction in bipolar disorder: Validation and evaluation of objective and subjective tools.
    Jensen JH; Støttrup MM; Nayberg E; Knorr U; Ullum H; Purdon SE; Kessing LV; Miskowiak KW
    J Affect Disord; 2015 Nov; 187():10-9. PubMed ID: 26301477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive deficits and psychosocial functioning in adult ADHD: Bridging the gap between objective test measures and subjective reports.
    Kallweit C; Paucke M; Strauß M; Exner C
    J Clin Exp Neuropsychol; 2020 Aug; 42(6):569-583. PubMed ID: 32757704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Working memory - not processing speed - mediates fluid intelligence deficits associated with attention deficit/hyperactivity disorder symptoms.
    Brydges CR; Ozolnieks KL; Roberts G
    J Neuropsychol; 2017 Sep; 11(3):362-377. PubMed ID: 26718618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How Informative Are Self-Reported Adult Attention-Deficit/Hyperactivity Disorder Symptoms? An Examination of the Agreement Between the Adult Attention-Deficit/Hyperactivity Disorder Self-Report Scale V1.1 and Adult Attention-Deficit/Hyperactivity Disorder Investigator Symptom Rating Scale.
    Silverstein MJ; Faraone SV; Alperin S; Biederman J; Spencer TJ; Adler LA
    J Child Adolesc Psychopharmacol; 2018 Jun; 28(5):339-349. PubMed ID: 29172673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atomoxetine treatment of attention-deficit/hyperactivity disorder in young adults with assessment of functional outcomes: a randomized, double-blind, placebo-controlled clinical trial.
    Durell TM; Adler LA; Williams DW; Deldar A; McGough JJ; Glaser PE; Rubin RL; Pigott TA; Sarkis EH; Fox BK
    J Clin Psychopharmacol; 2013 Feb; 33(1):45-54. PubMed ID: 23277268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No lower cognitive functioning in older adults with attention-deficit/hyperactivity disorder.
    Semeijn EJ; Korten NC; Comijs HC; Michielsen M; Deeg DJ; Beekman AT; Kooij JJ
    Int Psychogeriatr; 2015 Sep; 27(9):1467-76. PubMed ID: 25655491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WISC-III Cognitive Profiles in Children with ADHD: Specific Cognitive Impairments and Diagnostic Utility.
    Moura O; Costa P; Simões MR
    J Gen Psychol; 2019; 146(3):258-282. PubMed ID: 30729871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Neuropsychiatric Function in Phenylketonuria: Psychometric Properties of the ADHD Rating Scale-IV and Adult ADHD Self-Report Scale Inattention Subscale in Phenylketonuria.
    Wyrwich KW; Auguste P; Yu R; Zhang C; Dewees B; Winslow B; Yu S; Merilainen M; Prasad S
    Value Health; 2015 Jun; 18(4):404-12. PubMed ID: 26091594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive and emotional impairments in adults with attention-deficit/hyperactivity disorder and cocaine use.
    Wunderli MD; Vonmoos M; Niedecker SM; Hulka LM; Preller KH; Baumgartner MR; Kraemer T; Seifritz E; Schaub MP; Eich-Höchli D; Quednow BB
    Drug Alcohol Depend; 2016 Jun; 163():92-9. PubMed ID: 27085500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delay Aversion and Executive Functioning in Adults With Attention-Deficit/Hyperactivity Disorder: Before and After Stimulant Treatment.
    Low AM; le Sommer J; Vangkilde S; Fagerlund B; Glenthøj B; Sonuga-Barke E; Habekost T; Jepsen JRM
    Int J Neuropsychopharmacol; 2018 Nov; 21(11):997-1006. PubMed ID: 30124878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel multidomain computerized cognitive assessment for attention-deficit hyperactivity disorder: evidence for widespread and circumscribed cognitive deficits.
    Leitner Y; Doniger GM; Barak R; Simon ES; Hausdorff JM
    J Child Neurol; 2007 Mar; 22(3):264-76. PubMed ID: 17621495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of premorbid attention-deficit/hyperactivity disorder on neuropsychological functioning in individuals with acute mild traumatic brain injuries.
    Van Patten R; Keith C; Bertolin M; Wright JD
    J Clin Exp Neuropsychol; 2016; 38(1):12-22. PubMed ID: 26588804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.